S M Mansour Haeryfar Selected Research

Toll-Like Receptor 2

6/2009

Toll-like receptor 2 ligands on the staphylococcal cell wall downregulate superantigen-induced T cell activation and prevent toxic shock syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

S M Mansour Haeryfar Research Topics

Disease

18	Neoplasms (Cancer) 05/2023 - 05/2002
12	Infections 01/2023 - 01/2005
7	Septic Shock (Toxic Shock Syndrome) 05/2018 - 06/2009
3	Vesicular Stomatitis 04/2023 - 12/2021
3	Human Influenza (Influenza) 01/2023 - 01/2008
3	Virus Diseases (Viral Diseases) 01/2020 - 02/2011
3	Cytokine Release Syndrome 06/2017 - 01/2017
2	Melanoma (Melanoma, Malignant) 11/2023 - 01/2023
2	COVID-19 04/2023 - 12/2021
2	Sepsis (Septicemia) 01/2021 - 01/2015
2	Colonic Neoplasms (Colon Cancer) 01/2019 - 01/2014
2	Scarlet Fever 09/2017 - 05/2014
2	Rheumatoid Arthritis 07/2012 - 10/2010
2	Arthritis (Polyarthritis) 07/2012 - 10/2010
2	Influenza in Birds (Avian Flu) 03/2010 - 11/2009
2	Mastocytoma 03/2003 - 05/2002
1	Renal Cell Carcinoma (Grawitz Tumor) 05/2023
1	Ascites 05/2022
1	Ovarian Neoplasms (Ovarian Cancer) 05/2022
1	Ovarian Epithelial Carcinoma 05/2022
1	Hypersensitivity (Allergy) 01/2021
1	Superinfection 01/2020
1	Thymoma (Thymic Carcinoma) 10/2019
1	Inflammation (Inflammations) 01/2019
1	Skin Neoplasms (Skin Cancer) 01/2019
1	Polyps 01/2019
1	Leishmaniasis 01/2018
1	Disease Progression 01/2018
1	Gram-Positive Bacterial Infections 01/2017
1	Acquired Immunodeficiency Syndrome (AIDS) 11/2016
1	Communicable Diseases (Infectious Diseases) 10/2016
1	Bacteremia 09/2014
1	Abscess 09/2014

Drug/Important Bio-Agent (IBA)

10	SuperantigensIBA 01/2020 - 06/2009
9	LigandsIBA 01/2023 - 03/2008
7	Proteins (Proteins, Gene)FDA Link 04/2023 - 07/2012
6	VaccinesIBA 04/2023 - 01/2005
5	CytokinesIBA 01/2023 - 01/2008
4	AntigensIBA 10/2016 - 11/2009
4	GlycolipidsIBA 10/2016 - 03/2008
3	EpitopesIBA 01/2020 - 01/2008
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2023 - 05/2018
2	Neutralizing AntibodiesIBA 11/2022 - 12/2021
2	ChemokinesIBA 01/2021 - 09/2014
2	AntibodiesIBA 01/2020 - 09/2017
2	Antiviral Agents (Antivirals)IBA 01/2020 - 01/2019
2	Peptides (Polypeptides)IBA 01/2019 - 11/2017
2	Interleukin-17 (Interleukin 17)IBA 12/2018 - 01/2017
2	Histocompatibility Antigens Class IIIBA 05/2018 - 05/2014
2	staphylococcal enterotoxin BIBA 09/2017 - 06/2009
2	Virulence Factors (Pathogenicity Factors)IBA 09/2017 - 05/2014
2	nef Gene Products (nef Gene Product)IBA 01/2017 - 11/2016
2	HLA-DR4 Antigen (HLA DR4 Antigen)IBA 09/2014 - 07/2012
2	ExotoxinsIBA 05/2014 - 06/2009
2	CitrullineIBA 07/2012 - 10/2010
2	Galactosylceramides (Galactocerebrosides)IBA 02/2011 - 03/2008
2	Hemagglutinins (Hemagglutinin)IBA 03/2010 - 11/2009
1	Riboflavin (Vitamin B2)FDA LinkGeneric 01/2023
1	5- (2- oxopropylideneamino)- 6- d- ribitylaminouracilIBA 01/2023
1	Viral VaccinesIBA 01/2023
1	Immune Checkpoint InhibitorsIBA 01/2023
1	NivolumabIBA 01/2023
1	pembrolizumabIBA 01/2023
1	RNA (Ribonucleic Acid)IBA 05/2022
1	SolutionsIBA 12/2021
1	COVID-19 VaccinesIBA 12/2021
1	HaptensIBA 01/2021
1	Histocompatibility Antigens Class IIBA 01/2021
1	Granzymes (Granzyme)IBA 10/2019
1	6-carboxyfluorescein (carboxyfluorescein)IBA 01/2019
1	5-(6)-carboxyfluorescein diacetate succinimidyl ester (CFSE)IBA 01/2019
1	Peptide Hydrolases (Proteases)FDA Link 01/2019
1	CateninsIBA 01/2019
1	EstersIBA 01/2019
1	Monoclonal AntibodiesIBA 11/2018
1	MTOR InhibitorsIBA 01/2018
1	TOR Serine-Threonine KinasesIBA 01/2018
1	Bevacizumab (Avastin)FDA Link 12/2017
1	Cytokine Receptors (Cytokine Receptor)IBA 12/2017
1	Streptococcus pyogenes SpeA proteinIBA 09/2017
1	Immunoglobulins (Immunoglobulin)IBA 06/2017
1	Mucin-3IBA 06/2017
1	LipidsIBA 10/2016
1	Staphylococcal enterotoxin AIBA 09/2014
1	Interleukin-12 (IL 12)IBA 09/2014
1	Interferon-gamma (Interferon, gamma)IBA 09/2014
1	ToxoidsIBA 05/2014
1	erythrogenic toxinIBA 01/2014
1	Viral AntigensIBA 01/2014
1	Single-Chain AntibodiesIBA 01/2014
1	polycaprolactoneIBA 05/2013
1	Ethylene Oxide (Oxirane)IBA 05/2013
1	C-galactosylceramideIBA 07/2012

Therapy/Procedure

10	Immunotherapy 11/2023 - 03/2008
3	Fecal Microbiota Transplantation 11/2023 - 01/2023
3	Therapeutics 01/2021 - 02/2011
1	Punctures 01/2021
1	Ligation 01/2021
1	Drug Therapy (Chemotherapy) 12/2017
1	Critical Care (Surgical Intensive Care) 01/2015